Vitaline Postnatal
Natural health product licensed in Canada
- Other names
- Vitaline Post Natal Effervescent tablet
- Licence holder
- Naturapharma Inc.
- NPN or DIN-HM
- 80139522
- Status
- Active licence
- Licence date
- 25 March 2025
- Revision date
- Not provided
- Form
- Comprimé, effervescent
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 20 g | 2 g | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 2.8 Microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 5 Microgrammes | Not calculated |
| Fer Source : Pyrophosphate de fer (III) | 27 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 200 mg | Not calculated |
Non-medicinal ingredients
Saveur de fruit de la passion, Phosphate de calcium, tribasique, Acide citrique, Huile végétale, Sorbitol, Poly(éthylène glycol), Riboflavine 5'-phosphate de sodium, Glucose, Sucralose, Gomme arabique (acacia), Hydrogénocarbonate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 18 years | 1 Comprimé | 1 Tous les jours |
| Femmes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism. Helps in the development and maintenance of bones/cartilage/teeth/(and) gums. Helps pregnant women meet (the) (Health Canada's) recommended intake for iron, when taken in conjunction with a healthy diet. Helps to prevent iron deficiency anemia and associated tiredness and fatigue. Helps with immune function/the immune system. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Used in Herbal Medicine as a galactogogue/lactogogue to help promote milk production/secretion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80139522
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.